Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Amniotic fluid and maternal serum metabolic signatures in the 2nd trimester associated with pre-term delivery.

Virgiliou C, Gika HG, Witting M, Bletsou AA, Athanasiadis A, Zafrakas M, Thomaidis NS, Raikos N, Makrydimas G, Theodoridis GA.

J Proteome Res. 2017 Jan 9. doi: 10.1021/acs.jproteome.6b00845. [Epub ahead of print]

PMID:
28067049
2.

Immunohistochemical expression pattern of metastasis suppressor KISS-1 protein in adenomyosis lesions and normal endometrium.

Kolioulis I, Zafrakas M, Grimbizis G, Miliaras D, Timologou A, Bontis JN, Tarlatzis BC.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec 5;210:64-68. doi: 10.1016/j.ejogrb.2016.12.004. [Epub ahead of print]

PMID:
27940396
3.

Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials.

Zafrakas M, Papasozomenou P, Emmanouilides C.

World J Clin Oncol. 2016 Aug 10;7(4):331-6. doi: 10.5306/wjco.v7.i4.331.

4.

Quality-of-life changes over time in breast cancer patients undergoing breast-conserving surgery: a prospective study in Greece.

Eskitzis P, Zafrakas M, Papanicolaou A, Panagopoulou E, Gkoutzioulis M, Sympilidis G, Tarlatzis BC.

Arch Gynecol Obstet. 2016 Sep;294(3):639-45. doi: 10.1007/s00404-016-4098-6.

PMID:
27086287
5.

Immunohistochemical expression pattern of metastasis suppressors KAI1 and KISS1 in endometriosis and normal endometrium.

Timologou A, Zafrakas M, Grimbizis G, Miliaras D, Kotronis K, Stamatopoulos P, Tarlatzis BC.

Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:110-5. doi: 10.1016/j.ejogrb.2016.02.004.

PMID:
26918694
6.

Screening performance of different methods defining fetal nasal bone hypoplasia as a single and combined marker for the detection of trisomy 21 in the second trimester.

Papasozomenou P, Athanasiadis AP, Zafrakas M, Panteris E, Mikos T, Daniilidis A, Loufopoulos A, Assimakopoulos E, Tarlatzis BC.

J Matern Fetal Neonatal Med. 2016 Oct;29(20):3368-73. doi: 10.3109/14767058.2015.1127344.

PMID:
26635074
7.

Erratum to: Distinct demographic factors influence the acceptance of vaccination against HPV.

Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis T, Lampropoulos A; Lysistrata study group..

Arch Gynecol Obstet. 2015 Jul;292(1):207. doi: 10.1007/s00404-015-3631-3. No abstract available.

PMID:
25631344
8.

Endometriosis and ovarian cancer risk: a systematic review of epidemiological studies.

Zafrakas M, Grimbizis G, Timologou A, Tarlatzis BC.

Front Surg. 2014 May 8;1:14. doi: 10.3389/fsurg.2014.00014. Review.

10.

Fetal nasal bone length in the second trimester: comparison between population groups from different ethnic origins.

Papasozomenou P, Athanasiadis AP, Zafrakas M, Panteris E, Loufopoulos A, Assimakopoulos E, Tarlatzis BC.

J Perinat Med. 2016 Mar;44(2):229-35. doi: 10.1515/jpm-2014-0296.

PMID:
25503860
11.

Three-dimensional versus two-dimensional ultrasound for fetal nasal bone evaluation in the second trimester.

Papasozomenou P, Athanasiadis AP, Zafrakas M, Panteris E, Loufopoulos A, Assimakopoulos E, Tarlatzis BC.

J Matern Fetal Neonatal Med. 2015 Aug;28(12):1432-7. doi: 10.3109/14767058.2014.955002.

PMID:
25142106
12.

The effect of physical exercise on postpartum fitness, hormone and lipid levels: a randomized controlled trial in primiparous, lactating women.

Zourladani A, Zafrakas M, Chatzigiannis B, Papasozomenou P, Vavilis D, Matziari C.

Arch Gynecol Obstet. 2015 Mar;291(3):525-30. doi: 10.1007/s00404-014-3418-y.

PMID:
25138123
13.

Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.

Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, Lampropoulos AF; LYSISTRATA study group..

Eur J Cancer Prev. 2014 Sep;23(5):425-31. doi: 10.1097/CEJ.0000000000000060.

PMID:
24977385
14.

Obstetric and neonatal outcome after assisted fertilization and spontaneous conception: a comparative study.

Pados G, Zafrakas M, Tsolakidis D, Assimakopoulos E, Bili H, Tarlatzis BC.

Clin Exp Obstet Gynecol. 2012;39(4):448-51.

PMID:
23444740
15.

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.

Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T; LYSISTRATA Study Group..

Arch Gynecol Obstet. 2012 Jun;285(6):1719-24. doi: 10.1007/s00404-011-2208-z.

PMID:
22246478
16.

Prenatal diagnosis of thoracic kidney in the 2nd trimester with delayed manifestation of associated diaphragmatic hernia.

Athanasiadis AP, Zafrakas M, Arnaoutoglou C, Karavida A, Papasozomenou P, Tarlatzis BC.

J Clin Ultrasound. 2011 May;39(4):221-4. doi: 10.1002/jcu.20769.

PMID:
21480288
17.

New insights of osmoregulatory system changes in ovarian hyperstimulation syndrome.

Bili H, Tsolakidis D, Stangou M, Zafrakas M, Pados G, Memmos D, Tarlatzis BC.

Fertil Steril. 2011 Jan;95(1):304-6. doi: 10.1016/j.fertnstert.2010.08.008.

PMID:
20850728
18.

Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis.

Pavlidou E, Zafrakas M, Papadakis N, Benos A, Agorastos T.

Int J Gynecol Cancer. 2010 May;20(4):482-7. doi: 10.1111/IGC.0b013e3181d80a8f.

PMID:
20686368
19.

Time trends of female breast cancer mortality in Greece during 1980-2005: a population based study.

Pavlidou E, Zafrakas M, Papadakis N, Agorastos T, Benos A.

Postgrad Med J. 2010 Jul;86(1017):391-4. doi: 10.1136/pgmj.2009.091728.

PMID:
20364032
20.

Broad ligament leiomyosarcoma in a premenopausal nulliparous woman: case report and review of the literature.

Papachatzopoulos S, Theodoridis TD, Zafrakas M, Nikolakopoulos P, Molibas E.

Eur J Gynaecol Oncol. 2009;30(4):452-4. Review.

PMID:
19761145
Items per page

Supplemental Content

Loading ...
Support Center